Clinical Trials Logo

Clinical Trial Summary

Alcohol dependency is the most frequent addiction leading to a massive burden of both, patients health, and economy. Present therapeutic concepts suffer from limited efficacy, and thus new innovative therapies are needed. Neuroscientific studies have shown that prefrontal function in alcohol-dependent patients is impaired, leading to cognitive disturbances, and continuation of dependent behaviour. The results of pilot studies demonstrate that activation of prefrontal cortices via non-invasive brain stimulation improves cognitive performance in healthy subjects, and diminishes dependency-related behaviour in patients. The investigators aim to develop a stimulation protocol suited to induce a clinically relevant improvement of prefrontal functions in patients suffering from alcohol dependency. Therefore, the investigators will develop stimulation protocols which are able to modulate prefrontal activation for a much longer time course than those currently available, and will explore if the induced physiological alterations translate to respective cognitive improvements and reduction of addictive behaviour.


Clinical Trial Description

A hallmark of alcoholism is the deficiency of the frontal lobe, characterized by deficits in attention and working memory and executive dysfunction. This condition is especially marked by an inability to abstain from alcohol, having direct implications for the treatment of alcoholism (Goldstein and Volkow 2002).

In a previous study, we examined the frontal function by the Frontal Assessment Battery (FAB) and mental state through the Mini-Mental State Examination (MMSE) in 170 patients with alcoholism classified according to Lesch's typology (Zago-Gomes and Nakamura- Palacios 2009). In a global analysis, the alcoholics showed total scores on MMSE and FAB significantly smaller compared to non-alcoholics subjects. Type IV alcoholics showed lower scores on MMSE and FAB in comparison with non-alcoholics and all other types (Lesch's types I, II and III) of alcoholics. In a more specific analysis, even in alcoholics Type IV who had mental function (MMSE) preserved, the executive function (FAB) was significantly reduced (Zago-Gomes and Nakamura-Palacios 2009).

Moselhy et al. (2001) suggest that the frontal cognitive deficits observed in alcoholic patients are important predictors of therapeutic results. According to Lesch et al (1989, 1990, and in personal communication), Type IV alcoholics, who showed more severe frontal deficits are the ones who have the worst prognosis, with great difficulty in abstaining from alcohol, but still being treatable under intensive and multiple approaches. Therefore, investigations of new perspectives for the treatment of these alcoholics are especially needed.

A technique of neuromodulation that has been increasingly used and tested is the transcranial Direct Current Stimulation (tDCS). In this method, a weak direct current is induced in the cerebral cortex through two electrodes usually placed on the scalp (Nitsche et al 2008). Several studies have shown that this noninvasive method of brain stimulation is associated with significant changes in cortical excitability - increasing or decreasing it according to the polarity of stimulation (Nitsche and Paulus 2000, Nitsche and Paulus 2001; Zaghi et al 2009). Animal studies from the 50s and 60s showed that the effects of tDCS are associated with changes in the threshold of neuronal membrane at rest (Bindman et al 1964b; Purpura and McMurtry 1965). There is evidence that anodal transcranial stimulation improves cognitive function in man, and this effect seems to be due to a strengthening of glutamatergic synapses (Fregni et al 2005, Iyer et al 2005, Nitsche et al 2003).

In a recent study we examined the clinical and electrophysiological (indicated by the P3 component) effects of tDCS application over the left dorsolateral prefrontal cortex (DLPFC) in different types of alcoholics according to Lesch's typology (data submitted for publication). We enrolled 49 alcoholics aging between 18 and 75 years old during the subacute period of abstinence. These individuals were submitted to event-related potentials (ERP) under the presentation of sounds related or non-related to the use of alcohol before, during and after active tDCS (1mA, 35 cm2, for 10 minutes) or sham procedure at a randomized and counterbalanced order. We observed a significant improvement in the FAB performance after the active tDCS compared to sham in Type IV alcoholics. There was an increase in the amplitude of P3 mainly in frontal site (Fz). This change was also more pronounced in Type IV alcoholics. Thus, we found clinical and electrophysiological evidence of increased frontal activity induced by tDCS specific to the type IV alcoholics. Considering that the frontal dysfunction, may contribute to the loss of control over drinking behavior, these results suggest that a local increase in frontal activity induced by tDCS may have a beneficial clinical impact.

Therefore, in this project we intend to continue this study, aiming now to investigate the potential beneficial effects of tDCS applied repeatedly (once a week for 5 consecutive weeks) on the left DLPFC in the treatment of alcoholism in the course of protracted withdrawal. The frontal function will be examined by the application of FAB and other cognitive tests. A clinical follow-up will be carefully conducted.

General objective: The main objective of this study is to examine the potential beneficial effects of repetitive transcranial direct current electrical stimulation over the left dorsolateral prefrontal cortex in the treatment of alcoholism in the course of its protracted withdrawal.

Specific objectives: Of the specific objectives include the verification of the effects of repetitive transcranial electrical stimulation (5 applications) on: (1) the records of event-related potentials over 32 brain regions, (2) craving, (3) the performance of the frontal assessment battery, (4) the performance of two-back visual-spatial working memory task, (5) the performance of two-back auditory working memory task, (6) the performance of the inhibitory control behavior in a Go / No-Go task, (7) the performance of error detection, mental flexibility and inhibitory control in a counting Stroop test, (8) the quality of life.

This study recruited thirty three alcoholics with diagnosis confirmed by Diagnostic and Statistical Manual of Mental Disorders in its Fourth Edition (DSM-IV) who present themselves voluntarily for treatment of Alcohol Dependence Syndrome in the outpatient public service at University Hospital Cassiano Antonio de Moraes from Health Sciences Center from Federal University of Espirito Santo (PAA / HUCAM / CCS / UFES), which were clinically stable and not requiring hospitalization, with significant history of consumption of at least 35 weekly doses of alcohol on average last year, and an active intake of at least 35 weekly doses of alcohol in the last 90 days before starting the study, and yet, being in a minimum of seven days of abstinence until beginning of the study protocol. They signed a consent form and were distributed randomly in two groups (sham and tDCS groups). Registrations of visual-cued (neutral or alcohol-related images) event-related potential (ERPs)were done before and after repetitive bilateral (left cathodal/right anodal) transcranial Direct Current Stimulation (tDCS, 5 x 7 cm2, 2 mA, double application - 13 min duration with 20 min interval in between)over the dorsolateral prefrontal cortex or sham procedure. tDCS or sham tDCS were applied once a day for 5 consecutive days. Cognitive tests (frontal assessment battery - FAB, mini-mental status examination - MMSE, verbal n-back task, visuospatial n-back task, go/no-go task) were done at the beginning of the session 1 and session 6. They were weekly followed up for 4 additional weeks and monthly over the following 5 months. Treatment of acute withdrawal followed the routine in the outpatient service (diazepam, vitamins and general support). They were examined weekly at the outpatient service for 4 weeks after the end of the protocol. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01330394
Study type Interventional
Source Federal University of Espirito Santo
Contact
Status Completed
Phase Phase 2
Start date June 2011
Completion date July 2013

See also
  Status Clinical Trial Phase
Completed NCT02901041 - Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism Phase 3
Completed NCT03340051 - Remote Alcohol Monitoring and Episodic Thinking N/A
Completed NCT02486900 - Neurofeedback & Alcohol Dependence N/A
Completed NCT02705898 - Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women N/A
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02197598 - Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use Phase 4
Recruiting NCT02385643 - The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients N/A
Completed NCT01828866 - Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Active, not recruiting NCT01182766 - New Treatment for Alcohol and Nicotine Dependence Phase 2/Phase 3
Completed NCT02193204 - Chronic Alcohol, Stress Inflammatory Response and Relapse Risk N/A
Completed NCT01342549 - Treatment Strategy for Alcohol Use Disorders in Veterans With TBI Phase 3
Completed NCT01176591 - HBPL Study of the Impact of the NK1 Antagonist Aprepitant Phase 2
Completed NCT01165541 - A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency Phase 2
Completed NCT00585780 - Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse Phase 1/Phase 2
Completed NCT01056484 - Mindfulness Meditation for Health Phase 2
Completed NCT00607620 - Disseminating Organizational SBI Services at Trauma Centers N/A
Completed NCT00884884 - Aripiprazole and Topiramate on Free-Choice Alcohol Use Phase 2/Phase 3
Completed NCT00463346 - Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism Phase 3
Completed NCT00226694 - Alcohol and Gender Effects on Stress Circuit Function N/A